Sofia Fund portfolio company, Joylux, announces they have raised more than $9M exclusively through prominent angel investors and angel groups including the Sofia Fund and has expanded their Advisory Board by adding Dr. Michael Friedman, former FDA Commissioner.
Older post: Sofia Fund is a National Go-to Resource
Newer post: CogRX Gains Patent Coverage in Japan and China